Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy

This study assessed the use of pretreatment albumin–-bilirubin (ALBI) grade as a prognostic factor in patients with hepatocellular carcinoma (HCC) receiving combined transarterial chemoembolization (TACE) and radiotherapy (RT). Patients who underwent RT following TACE between January 2011 and Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jason Joon Bock, Park, Jun Su, Hong, Hyun Pyo, Kim, Myung Sub, Koo, Dong-Hoe, Lee, Hyebin, Nam, Heerim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963241/
https://www.ncbi.nlm.nih.gov/pubmed/36836588
http://dx.doi.org/10.3390/jpm13020354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963241/
https://www.ncbi.nlm.nih.gov/pubmed/36836588
http://dx.doi.org/10.3390/jpm13020354

Ejemplares similares